Font Size: a A A
Keyword [Hsp90 inhibitor]
Result: 41 - 60 | Page: 3 of 4
41. Study On Synthesis Process Of AT13387 As Hsp90 Inhibitor
42. Preparation Of Microkernel-based Mesoporous(SiO2-CdTe-SiO2)@SiO2 Fluorescent Nanoparticles For Imaging Screening And Enrichment Of Heat Shock Protein 90 Inhibitors From Tripterygium Wilfordii
43. Treatment Of Osteosarcoma With Mild Microwave Ablation Combined With HSP90 Inhibitor And TGF-?1 Inhibitor
44. Effects Of C086 Combined With Imatinib On GIST-882 Cells
45. The Study On The Mechanism Of Hsp90 Inhibitor 17-DMAG Inducing Apoptosis Of Acute Lymphoblastic Leukemia Cells Via Autophagy-lysosome Pathway
46. Design,Synthesis And Activity Evaluation Of O-Nitrophenoxyacetyl CPMPu Derivatives As Antitumor HSP90 Inhibitor
47. The Mechanism Research On HER2-positive Esophagus Cancer Cell OE19 Resistance To Hsp90 Inhibitor 17-AAG
48. The Synergistic Inhibitory Effects Of A PLK1 Inhibitor And An HSP90 Inhibitor Against Proliferation Of Gastric Cancer Cells
49. The Hsp90 Inhibitor Ganetespib Synergizes With The Triptolide In Human Leukemia Cell Lines
50. 17-AAG Synergizes With Belinostat To Exhibit A Negative Effect On The Proliferation And Invasion Of MDA-MB-231 Breast Cancer Cells
51. HSP90 Inhibitor Ganetespib(STA-9090) Inhibits Tumor Growth In C-Myc-dependent Esophageal Squamous Cell Carcinoma
52. HSP90 Inhibitor 17-AAG Inhibits Migration And Invasion Of Anaplastic Thyroid Carcinoma By Down-regulating HIF-1?
53. Total synthesis of Hsp90 inhibitor geldanamycin
54. (-)-Epigallocatechin-3-gallate, found in the green tea extract, in a novel Hsp90 inhibitor
55. A novel Hsp90 inhibitor to disrupt Hsp90/p50Cdc37 complex for pancreatic cancer therapy
56. Identification Of C0818,a Novel Curcumin Derivative As Antitumor And Senolytic Agent Through Disruption Of Hsp90 Function In Human Hepatocellular Carcinoma Cells
57. Structure Optimization And Antiviral Structure-activity Relationship Study Of Hsp90 Inhibitor-geldanamycin
58. Study Of Effects Of HSP90 Inhibitor Ganetespib On The Sensitivity Of Mantle Cell Lymphoma To The BTK Inhibitor Ibrutinib And The Relevant Mechanisms
59. Study Of HSP90 Inhibitor Ganetespib Increasing The Sensitivity Of Mantle Cell Lymphoma Cells To The PARP Inhibitor And Investigation Of The Mechanism
60. Inhibitory Effect Of Hsp90 Inhibitor STA9090 On Esophageal Squamous Cell Carcinoma And The Molecular Mechanism
  <<First  <Prev  Next>  Last>>  Jump to